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SUMMARY
Testicular microlithiasis (TML) is an incidental finding at ultrasonography of the scrotum. A link between testicular microlithiasis
and testicular cancer has been suggested. However, the majority of studies are retrospective using ultrasonography with minor data
on health status and life style characteristics. Our objective was to investigate if lifestyle and health are associated with TML. In 2014,
we conducted a self-administered questionnaire survey including 1538 men, who all due to testicular/scrotal symptoms had an ultra-
sound investigation of the scrotum during 2004–2013. The men were divided into men with TML and men without. The 23-items
questionnaire included items on age, height, weight, lifestyle (alcohol consumptions, smoking habits, workload, exercise and food),
previous diseases in the testicles, pain and consumption of analgesics. The prevalence of TML was 12.8%. Overall, lifestyle factors
did not vary between men with or without TML. However, men with TML did consume more crisp than men without. Development
of TML was not associated to classic life style factors such as alcohol consumption, smoking habits, or mothers smoking during preg-
nancy. Also, age and height could not be linked to presence of TML. We did find, however, that men with TML experienced less phys-
ical activity and consumed more crisp than men without TML. Since ingestion of crisps has potential carcinogenic effect
(acrylamide), this finding needs confirmation in a separate study.
INTRODUCTION
Testicular microlithiasis (TML) is as an incidental finding by
ultrasonography (US) of the scrotum. TML was described by
Doherty et al. (1987) as innumerable tiny bright echoes diffusely
and uniformly scattered throughout their substance. The inci-
dence of TML has increased with the development of more high-
end ultrasound machines, and perhaps also increased awareness
of diagnosis of testicular cancer. TML prevalence varies consid-
erably in studies of asymptomatic men (0.6–9.0%) (Derogee
et al., 2001; Miller & Sidhu, 2002; Kim et al., 2003; Goede et al.,
2009) compared to symptomatic (e.g. pain, lump or swelling)
men (8.7–18.1%) (Bach et al., 2001; Middleton et al., 2002; Dega-
nello et al., 2012). In populations with genetic disorders, the
prevalence of TML has been reported as high as 17.5% in men
with Klinefelter syndrome (Accardo et al., 2015) and 36.0% in
men with Down’s syndrome (Cebeci et al., 2015).
TML has been associated with carcinoma in situ and testicu-
lar cancer (Derogee et al., 2001; Sakamoto et al., 2006); how-
ever, not all studies have found this association (Peterson
et al., 2001; Costabile, 2007; DeCastro et al., 2008; Goede et al.,
2009; Accardo et al., 2015). A recent meta-analysis including
more than 35 000 men concluded that TML was significantly
associated with risk of testicular cancer (Wang et al., 2015).
Still, it is not evident whether there is a causal relationship or
the association is a result of confounding by indication. In
2015, the first guideline was published by the European Soci-
ety of Urogenital Radiology (ESUR) recommending yearly US
follow-up in men with TML and additional risk factors (per-
sonal/family history of testicular cancer, maldescent, orchi-
dopexy, atrophy or genetic disease) (Richenberg et al., 2015).
The risk factors for testicular cancer are not clear, but there
are some acknowledged or suggested risk factors for example,
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cryptorchidism (Cook et al., 2010), height (Wiren et al., 2014),
family history (Nordsborg et al., 2011) and maternal smoking
(Pettersson et al., 2004). The majority of TML studies are retro-
spective with limited background information. Thus, there is a
need for more knowledge about lifestyle and health in men
with TML, in order to understand if lifestyle influences devel-
opment of TML.
The aim of this study was to investigate if lifestyle and health
were associated with TML.
MATERIALS ANDMETHODS
A 23-item self-administered questionnaire was in 2014 mailed
to men who all had undergone an US investigation of the scro-
tum in a 10-year period. After returning the questionnaires, the
men were categorised into men with or without TML, based on
the result of their previous US. The questionnaire was explicitly
developed to gain more knowledge about TML.
Study population
All men who had an US investigation of the scrotum in our
radiology department between 01.01.2004 and 31.12.2013 were
identified in the Roentgen Information System (RIS), which
included patient’s unique civil registration number (Lynge et al.,
2011), referral, date of investigation and the medical US conclu-
sion. The civil registration number was used to collect informa-
tion in biopsies and cancer subtype when relevant.
A total of 2610 men were identified. Because of death,
unknown address, having left the country, under the age of
18 years at the date of investigation, a total of 2277 men were
mailed a questionnaire. A total of 1214 (53.3%) questionnaires
were returned, including 21 who did not wish to participate, 11
with unknown address and eight returned an unidentified ques-
tionnaire and were excluded, leaving 1174 questionnaires eligi-
ble (51.6%). A reminding letter was mailed after four weeks and
further 369 questionnaires were returned, of which five individu-
als did not want to participate. This left us with a total of 1538
questionnaires (67.5%) (Figure 1).
All the questionnaires were entered into two databases sepa-
rately by two of the authors (MRP and MMJ), and compared in
order to identify any discrepancies, which were then revised.
All US examinations were performed by one of three scanners;
either a 9L4 linear array transducer from Siemens (Siemens,
Acuson, S2000, Mountain View, CA, USA/Siemens, Acuson,
S3000) or with 14-6 linear array transducer from Hitachi (Hita-
chi, EUB-8500, Tokyo, Japan).
Questionnaire
The 23 items included questions about age, height, weight and
lifestyle items on food and alcohol consumptions, smoking habits,
exercise, previous diseases in the testicles and consumption of
analgesic. Multiple answers for a single item were not allowed.
The questionnaire was developed to describe the concepts of
health and lifestyle among the men. It included a broad area of
both self-reported experience of testicular symptoms, a broad
number of food and drink consumptions and personal charac-
teristics. Items related to testicular cancer, frequently presented
symptoms by patients referred to US investigation of the scro-
tum and ad hoc items were also included.
The patients were asked, how often they consumed a broad
various of food and drink with response categories ‘more than
once a day’, ‘5–7 times a week’, ‘3–4 times a week’, ‘1–2 times a
week’, ‘1–3 times a month’ and ‘rarer’. In the analyses, these were
dichotomised into ‘more than once a week’ and ‘less than once a
week’ with the latter including all other response categories than
‘5–7 times a week’, ‘3–4 times a week’ and ‘1–2 times a week’.
To establish content validity in the questionnaire, four radiolo-
gists commented on the included aspects, words or formula-
tions. The radiologists were all skilled in US, and all dealt on a
daily basis with US investigation of the scrotum. In addition, we
performed a pilot study among five patients, after they had com-
pleted an US investigation of the scrotum. Afterwards, one
author (MRP) interviewed each patient concerning content and
comprehension of the questionnaire, answer categories, length
of questionnaire and time consumption.
After revision, a second pilot study was performed, among 26
randomly selected men after they had undergone an US of the
scrotum. They filled out the 23-item questionnaire and orally
commented on it to one of the authors (MRP). Based on the pilot
questionnaire, we adjusted one question (question 20) and
added an extra disease category. In the pilot, we assessed the
Figure 1 Flow chart of the questionnaires.
[Colour figure can be viewed at wileyonline
library.com].
© 2017 American Society of Andrology and European Academy of Andrology Andrology, 2017, 5, 556–561 557
CHARACTERISTICS OF SYMPTOMATIC MEN ANDROLOGY
data for missing data and floor and ceiling effects, and adjusted
the answer categories.
Statistical analysis
The data were analysed using STATA (version 14.1, STATA Cor-
poration, College Station, TX, USA). The 95% confidence intervals
(95%CI) for odds ratios (OR) were calculated by logistic regres-
sion and p-values ≤5% were considered statistically significant.
Ethics and approval
The study was approved by the National Data protection
Agency, and the Regional Scientific Ethic Committee for South-
ern Denmark (ID: S-20120144) and the national board of health.
RESULTS
In the identified study population of 2277 men, a total of 270
had TML (prevalence of 11.9%). Among the 1538 responding
men included in the analyses, 197 (12.8%) men had TML. The
mean age in men with TML was 51.9 years (18–89) compared to
54.3 years (18–93) for men without TML (p = 0.056).
Overall, there were limited differences in health and lifestyle
between men with or without TML (Tables 1 and 2). Men with
TML reported to consume crisp and popcorn more often (36.6%
vs. 22.0%, p < 0.001), reported less physical exercise (38.6% vs.
48.2%, p = 0.011), and experienced more often testicular dis-
comfort (34.5% vs. 27.7%, p = 0.058) than men without TML.
Trauma to the testicles was reported more often in men with
TML than in men without TML (8.6% vs. 5.3%, p = 0.065). A total
of 27.9% of the TML men reported their mother smoked during
pregnancy compared to 23.1% of men without TML (p = 0.135).
Table 3 shows the most common causes of referral to US
investigation. Pain was most common in both groups of men
(32.2% in men with TML vs. 27.1% in men without, p = 0.151).
Table 4 shows the difference between men with and/or with-
out TML and the number of received US scans. Men without
TML had less US investigations performed than men with TML.
A total of 167 (84.7%) of the 197 men with TML were diagnosed
with TML at their first US investigation. Leaving 30 of the TML
men with a later diagnosis of TML with a median time from first
US until TML diagnosis of 56.2 months (min-max = 2.3–92.1,
interquartile interval = 14.2–77.9).
Seventy-two (4.7%) of the 1538 responding men had a total of
112 biopsies [17 (23.6%) with and 55 (76.4%) without TML], giv-
ing a relative risk of having a biopsy of 2.0 (1.1–3.4) among men
with TML. A total of 36 (32%) of the biopsies were of the con-
tralateral testicle.
A total of 46 cancers were diagnosed in 43 men (2.8%) [11 men
with TML (5.6%) and 32 men without TML (2.4%), OR = 2.4 (1.1–
5.0), p = 0.011] (Table 5). The mean age in men with testicular
cancer was 42.5 (21–85) years. A total of 29 seminomas were
diagnosed, seminoma being the most common cancer subtype
in both groups. Four of the 43 men developed a testicular cancer
between 1 and 3 years after US investigation and two of these
men had TML.
DISCUSSION
Main findings
In general, there were limited differences in health and life-
style among men with or without TML. Men with TML reported
Table 1 Information of age distribution and other characteristics of men with and without testicular microlithiasis (TML)
Variables Men with TML Men without TML Age adjusted
N = 197 % N = 1341 % OR L H
Age
0–29 11 5.6 94 7.0 0.63 0.31 1.25
30–39 31 15.7 168 12.5 0.99 0.61 1.60
40–49 53 26.9 284 21.2 1.00
50–59 42 21.3 270 20.1 0.83 0.54 1.29
60–69 33 16.8 265 19.8 0.67 0.42 1.06
70+ 27 13.7 260 19.4 0.56 0.34 0.91
Height ≥180 cm vs. <180 cm 108 54.8 672 40.1 1.12 0.82 1.53
BMI of 25–30 vs. <25 84 42.6 576 43.0 0.99 0.71 1.37
Smoking ever vs. no smoking 107 54.3 714 53.2 0.91 0.82 1.00
≥15 vs. <15 cigarette pack year 63 32.0 422 31.5 0.89 0.53 1.47
Mother smoking during pregnancy vs. no smoking 55 27.9 310 23.1 1.27 0.89 1.80
No alcohol consumption vs. alcohol consumption during
the last 12 months
10 5.1 75 5.6 0.92 0.46 1.80
≥6 cups of coffee vs. <5 cups per day 51 25.9 346 25.8 1.02 0.72 1.45
≥3 cups of Tea vs. <2 cups per day 13 6.6 90 6.7 0.97 0.50 1.91
Idle work vs. lifting 79 40.1 491 36.6 1.15 0.76 1.75
>6 h vs. never sitting down during work hours 33 16.7 245 18.3 0.90 0.52 1.57
>6 h vs. never walking and standing during work hours 30 15.2 259 19.3 0.82 0.45 1.49
Sitting down ≥5 h vs. <5 h 34 17.2 196 14.6 1.27 0.84 1.91
30 min or less vs. never biking hours per day 33 16.7 195 14.5 1.18 0.76 1.83
Yes vs. no regular exercise 76 38.6 646 48.2 0.71 0.52 0.98
Yes vs. no testicular pain during the last 6 months 54 27.4 306 22.8 1.24 0.88 1.74
Yes vs. no testicular discomfort 68 34.5 372 27.7 1.29 0.93 1.79
Inflammation vs. never inflammation 38 19.3 227 16.9 1.20 0.82 1.77
Trauma vs. never trauma 17 8.6 72 5.4 1.58 0.90 2.75
Torsion vs. never torsion 10 5.1 41 3.1 1.58 0.78 3.24
Monthly vs. yearly use of painkillers 78 39.6 452 33.7 1.33 0.95 1.86
Use vs. no use of paracetamol 116 58.9 874 65.2 0.79 0.58 1.08
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less physical exercise than men without TML, had a higher con-
sumption of crisp and experienced more testicular discomfort.
Developing TML in testicles appears in general independent
of lifestyle factors such as food and soft drink consumption,
alcohol, BMI and smoking.
Secondarily, a total of 43 men were diagnosed with cancer
(2.8%), and the presence of TML was significantly associated
with cancer compared to no TML (5.6% vs. 2.4%) (p = 0.011).
TML has previously been suggested to be a pre-malignant condi-
tion (Derogee et al., 2001; Wang et al., 2015). In our study, testic-
ular cancer was associated with TML; however, the study was
not designed to elucidate a possible causal link.
Seminoma was the most frequent cancer subtype in both
groups. TML has been suggested associated with seminoma
(McDonald et al., 2012; Sharmeen et al., 2015; Pedersen et al.,
2016). Of the 29 seminomas, a total of 23 (79.3%) men did not
have TML and six (20.7%) were diagnosed with TML. This obser-
vation questions the suggested association between TML and
seminoma.
Additionally, we found that TML may develop over time, as 30
out of 197 men were not diagnosed with TML at their first US
investigation. In general, men with TML had more US investiga-
tions performed than men without TML, which was expected
because of follow-up in these patients.
Strengths and weaknesses of the study
A strength of this study was the use of a clinical radiological
database for registration of the TML diagnosis. Furthermore,
because of the Danish civil registration number, it was possible
to link data with biopsies performed and cancer subtype. We
investigated a wide range of self-reported health and scrotal
symptoms, which has not previously been reported in men with
TML. This study enjoyed a relative high response rate, which
reduced the risk of selection bias. Still, one-third did not partici-
pate which may lead to a selection bias associated with having
the diagnosis TML. However, as the proportion of TML in
responders was the same in the study base, the potential selec-
tion bias probably may be ignored.
Table 2 Patient’s soft drink and food consumption
Variables Men with TML Men without TML Age adjusted
N = 197 % N = 1342 % OR L H
Soft drink with sugar
More than once a week vs. less than once a week 103 52.3 709 52.9 0.89 0.64 1.22
Soft drink without sugar
More than once a week vs. less than once a week 84 42.6 506 37.7 1.16 0.85 1.58
Cake, candy, Ice cream
More than once a week vs. less than once a week 156 79.2 1037 77.3 1.04 0.71 1.53
Crisps, popcorn etc
More than once a week vs. less than once a week 72 36.6 295 22.0 1.95 1.39 2.73
Fast-food
More than once a week vs. less than once a week 39 19.8 215 16.0 1.19 0.80 1.76
Meat
More than 3 times a week vs. <3 times a week 144 73.1 966 72 1.01 0.72 1.42
Poultry
More than 3 times a week vs. <3 times a week 55 27.9 327 24.4 1.11 0.79 1.58
Fish
More than once a week vs. less than once a week 136 69.0 853 63.6 1.33 0.96 1.85
Vegetable/vegan dishes
More than once a week vs. less than once a week 122 62.0 797 59.4 1.15 0.84 1.57
Table 3 The referral reasons to ultrasonic investigation of scrotum in the
two groups
Reasons for referral Men with TML Men without
TML
p-value
N % N %
Testicular pain 63 32.2 363 27.1 0.151
Nodule/lump 41 20.9 257 19.2 0.585
Soreness 43 21.9 311 23.2 0.671
Swelling 23 11.8 234 17.5 0.044
Others 26 13.2 175 13.0 0.954
Total 197 100.0 1341 100.0
Table 4 The number of US investigations the patients were referred to in
the period 2004–2013
Number of US
investigations
Men with TML Men without TML
N % N %
1 105 53.3 1095 81.6
2 55 28.0 186 13.9
3 17 8.6 41 3.1
4 6 3.0 12 0.9
5+ 14 7.1 7 0.5
Total 197 100.0 1341 100.0
Table 5 Overview of the 46 malignancy biopsies in 43 men (three of the
men had malignancy in both testicles)
Cancer type Men with TML Men without
TML
Total
N % N %
Seminoma 6 20.7 23 79.3 29
Carcinoma in situ 1 100.0 0 0 1
Teratoma 1 33.3 2 66.7 3
Leydig cell tumour 0 0.0 1 100.0 1
Adenomatoid tumour 0 0.0 3 100.0 3
B-cell lymphoma 1 100.0 0 0.0 1
Germinal cell tumour 2 28.6 5 71.4 7
Lipoid sarcoma 1 100.0 0 0.0 1
Total 12 26.1 34 73.9 46
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The questionnaires were used in a paper version and not as a
web-based version, which may have increased the response rate,
especially among elderly men. The questionnaire were mailed to
men who had an US investigation of the scrotum in the period
2004–2013, and this might have introduced recall bias from
some of the responders. Some may have forgotten about the
experience of symptoms, and a handful of men phoned because
they have elapsed receiving an US investigation in our depart-
ment. However, in all questions concerning lifestyle, we asked
the men how many cigarettes they smoked, and what they have
been eating and drinking during the last couple of months,
hence recall bias was limited.
Comparison with other findings
Our study is the first to investigate health in men with TML.
ESUR provided in 2015 a guideline (Richenberg et al., 2015) sug-
gesting men with TML and additional risk factors, such as family
history of testicular cancer, testicular atrophy, maldescent and
orchidopexy should be advised to participate in annual US fol-
low-up until aged 55 years. We did not find any additional risk
factors to be considered when offering men with TML yearly US
follow-up. Men with TML reported significantly less physical
exercise than men without TML. A review from 2015 investigated
the exercise, testicular diseases and reproductive function con-
cluding that the impact of exercise in male reproductive func-
tions remains controversial (Gomes et al., 2015). Our data
suggest that there may be an association.
Overall, developing TML in testicles appears not to be influ-
enced by lifestyle factors. However, men with TML consumed
more crisp and popcorn than men without TML. Crisp and pop-
corn contains acrylamide, and it is known for its potential health
hazards. A study from 2003 investigated the concentration of
acrylamide in crisps and found the highest concentration in
potato crisps but also potato chips and popcorn had a high con-
centration (Murkovic, 2004). In some studies, rodent acrylamide
has been shown to generate tumours in multiple organs, includ-
ing mesotheliomas of the testicles (Johnson et al., 1986; Fried-
man et al., 1995; Klaunig, 2008). In a study from 2013, the intake
of acrylamide was investigated in 10 European countries, and on
average, Denmark and the UK had the highest dietary self-
reported intake of acrylamide (Freisling et al., 2013). Our data
may suggest that further studies are needed in this area, for
example, investigating asymptomatic men.
In our department, men with TML were more often US investi-
gated than men without TML because men with TML were
invited to participate in the follow-up programme with scans
every 6th month in a period of 2 years. Testicular pain was the
most frequent referral reason to US investigation, and men with
TML tended more often to have testicular pain than men with-
out. Thus, another reason why men with TML are investigated
more often could be the experience of pain in the scrotum.
Patients with genetic disorders like McCune–Albright syn-
drome, Down syndrome and Klinefelter syndrome appear to
have very high frequencies of TML. A recent review did not find
TML in patients with McCune–Albright or Down syndrome to be
associated with development of testicular cancer (Pedersen
et al., 2016). It should be noted, however, that males with Down
syndrome generally have a higher risk of testicular cancer (Patja
et al., 2006). Furthermore, a recent study did not find increased
development of testicular cancer in Klinefelter patients (Accardo
et al., 2015). Instead, the association between TML and genetic
abnormalities may indicate TML as part of a degenerative pro-
cess of the testis.
In some studies, mothers smoking during pregnancy have
been associated with testicular cancer in the male offspring (Kai-
jser et al., 2003; Pettersson et al., 2004). We found an insignifi-
cant tendency that men with TML had been more exposed to
maternal smoking than men without TML.
Wiren et al., (2014) found that increasing height was associ-
ated with increased risk of testicular cancer. Similarly a meta-
analysis from 2010 (Lerro et al., 2010) found height per 5-cm
increase (OR 1.13) to be associated with testicular germ cell
tumour. No difference in height between men with or without
TML was seen in our study.
CONCLUSION
Development of TML was not associated with classic lifestyle
factors such as alcohol consumption, smoking habits or mothers
smoking during pregnancy. Also, age and height could not be
linked to presence of TML. We did find, however, that men with
TML experienced less physical activity and consumed more
crisp than men without TML. As ingestion of crisps has potential
carcinogenic effect (acrylamide), this finding needs confirmation
in a separate study.
ACKNOWLEDGEMENTS
The authors thank the participating men for completing the
questionnaires, and to all the secretaries, especially Maybrith S.
Klink, Birgit Fløjstrup and Marie Hulsrøj from the department of
radiology; Vejle Hospital for helping with enveloping and mail-
ing the questionnaires. The Region of Southern Denmark, and
the Union of Radiographers in Denmark supported this study.
CONFLICT OF INTEREST
The authors have no conflicts of interest to declare.
AUTHORS’ CONTRIBUTIONS
MRP, HM, SSR and PV were involved in study conception and
design. MRP, MMJ and PV were involved in study execution and
acquisition of data. MRP, HM and PV contributed to data analy-
sis and interpretation. MRP, HM, PV, PJO, SRR drafted the
manuscript. All authors provided substantial intellectual contri-
bution and approved the final version of the manuscript.
REFERENCES
Accardo G, Vallone G, Esposito D, Barbato F, Renzullo A, Conzo G,
Docimo G, Esposito K & Pasquali D. (2015) Testicular parenchymal
abnormalities in Klinefelter syndrome: a question of cancer?
Examination of 40 consecutive patients. Asian J Androl 17, 154–158.
Bach AM, Hann LE, Hadar O, Shi W, Yoo HH, Giess CS, Sheinfeld J &
Thaler H. (2001) Testicular microlithiasis: what is its association with
testicular cancer? Radiology 220, 70–75.
Cebeci AN, Aslanger A & Ozdemir M. (2015) Should patients with Down
syndrome be screened for testicular microlithiasis ? Eur J Pediatr Surg
25, 177–180.
Cook MB, Akre O, Forman D, Madigan MP, Richiardi L & McGlynn KA.
(2010) A systematic review and meta-analysis of perinatal variables in
relation to the risk of testicular cancer-experiences of the son. Int J
Epidemiol 39, 1605–1618.
Costabile RA. (2007) How worrisome is testicular microlithiasis? Curr
Opin Urol 17, 419–423.
560 Andrology, 2017, 5, 556–561 © 2017 American Society of Andrology and European Academy of Andrology
M. R. Pedersen et al. ANDROLOGY
DeCastro BJ, Peterson AC & Costabile RA. (2008) A 5-year followup study
of asymptomatic men with testicular microlithiasis. J Urol 179, 1420–
1423.
Deganello A, Svasti-Salee D, Allen P, Clarke JL, Sellars ME & Sidhu PS.
(2012) Scrotal calcification in a symptomatic paediatric population:
prevalence, location, and appearance in a cohort of 516 patients. Clin
Radiol 67, 862–867.
Derogee M, Bevers RFM, Prins HJ, Jonges TG, Elbers FH & Boon TA.
(2001) Testicular microlithiasis, a premalignant condition: prevalence,
histopathologic findings, and relation to testicular tumor. Urology 57,
1133–1137.
Doherty F, Mullins TL, Sant GR, Drinkwater MA & Ucci AA Jr. (1987)
Testicular microlithiasis. A unique sonographic appearance. J
Ultrasound Med 6, 389–392.
Freisling H, Moskal A, Ferrari P, Nicolas G, Knaze V, Clavel-Chapelon F,
Boutron-Ruault MC, Nailler L, Teucher B, Grote VA, Boeing H,
Clemens M, Tjønneland A, Olsen A, Overvad K, Quiros JR, Duell EJ,
Sanchez MJ, Amiano P, Chirlaque MD, Barricarte A, Khaw KT,
Wareham NJ, Crowe FL, Gallo V, Oikonomou E, Naska A,
Trichopoulou A, Palli D, Agnoli C, Tumino R, Polidoro S, Mattiello A,
Bueno-de-Mesquita HB, Ocke MC, Peeters PH, Wirf€alt E, Ericson U,
Bergdahl IA, Johansson I, Hjartaker A, Engeset D, Skeie G, Riboli E &
Slimani N. (2013) Dietary acrylamide intake of adults in the European
Prospective Investigation into Cancer and Nutrition differs greatly
according to geographical region. Eur J Nutr 52, 1369–1380.
Friedman MA, Dulak LH & Stedham MA. (1995) A lifetime oncogenicity
study in rats with acrylamide. Fundam Appl Toxicol 27, 95–105.
Goede J, Hack WWM, van der Voort-Doedens LM, Sijstermans K & Pierik
FH. (2009) Prevalence of testicular microlithiasis in asymptomatic
males 0 to 19 years old. J Urol 182, 1516–1520.
Gomes M, Freitas MJ & Fardilha M. (2015) Physical activity, exercise, and
mammalian testis function: emerging preclinical protein biomarker
and integrative biology insights. OMICS 19, 499–511.
Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman
MA & Mast RW. (1986) Chronic toxicity and oncogenicity study on
acrylamide incorporated in the drinking water of Fisher 344 rats.
Toxicol Appl Phamacol 85, 154–168.
Kaijser M, Akre O, Cnattingius S & Ekbom A. (2003) Maternal lung cancer
and testicular cancer risk in the offspring. Cancer Epidemiol
Biomarkers Prev 12, 643–646.
Kim B, Winter TC & Ryu JA. (2003) Testicular microlithiasis: clinical
significance and review of the literature. Eur Radiol 13, 2567–2576.
Klaunig JE. (2008) Acrylamide carcinogenicity. J Agric Food Chem 56,
5984–5988.
Lerro CC, McGlynn KA & Cook MB. (2010) A systematic review and meta-
analysis of the relationship between body size and testicular cancer.
Br J Cancer 103, 1467–1474.
Lynge E, Sandegaard JL & Rebolj M. (2011) The Danish national patient
register. Scand J Public Health 39, 30–33.
McDonald MW, Reed AB, Tran PT & Evans LA. (2012) Testicular tumor
ultrasound characteristics and association with histopathology. Urol
Int 89, 196–202.
Middleton WD, Teefey SA & Santillan CS. (2002) Testicular microlithiasis:
prospective analysis of prevalence and associated tumor. Radiology
224, 425–428.
Miller FNAC & Sidhu PS. (2002) Does testicular microlithiasis matter? A
review. Clin Radiol 57, 883–890.
Murkovic M. (2004) Acrylamide in Austrian foods. J Biochem Biophys
Methods 61, 161–167.
Nordsborg RB, Meliker JR, Wohlfahrt J, Melbye M & Raaschou-Nielsen O.
(2011) Cancer in first-degree relatives and risk of testicular cancer in
Denmark. Int J Cancer 129, 2485–2491.
Patja K, Pukkala E, Sund R, Livanainen M & Kaski M. (2006) Cancer
incidence of persons with Down syndrome in Finland: a population-
based study. Int J Cancer 118, 1769–1772.
Pedersen MR, Rafaelsen SR, Møller H, Vedsted P & Osther PJ. (2016)
Testicular microlithiasis and testicular cancer: review of the literature.
Int Urol Nephrol 48, 1079–1086.
Peterson AC, Bauman JM, Light DE, McMann LP & Costabile RA. (2001)
The prevalence of testicular microlithiasis in an asymptomatic
population of men 18 to 35 years old. J Urol 166, 2061–2064.
Pettersson A, Kaijser M, Richiardi L, Askling J, Ekbom A & Akre O. (2004)
Women smoking and testicular cancer: One epidemic causing
another? Int J Cancer 109, 941–944.
Richenberg J, Belfield J, Ramchandani P, Rocher L, Freeman S, Tsili AC,
Cuthbert F, Studniarek M, Bertolotto M, Turgut AT, Dogra V & Derchi
LE. (2015) Testicular microlithiasis imaging and follow-up: guidelines
of the ESUR scrotal imaging subcommittee. Eur Radiol 25, 323–330.
Sakamoto H, Shichizyou T, Saito K, Okumura T, Ogawa Y, Yoshida H &
Kushima M. (2006) Testicular microlithiasis identified
ultrasonographically in Japanese adult patients: prevalence and
associated conditions. Urology 68, 636–641.
Sharmeen F, Rosenthal MH, Wood MJ, Tirumani SH, Sweeney C &
Howard SA. (2015) Relationship between the pathologic subtype/
initial stage and microliths in testicular germ cell tumors. J Ultrasound
Med 34, 1977–1982.
Wang T, Liu L, Luo J, Liu T & Wei A. (2015) A meta-analysis of the
relationship between testicular microlithiasis and incidence of
testicular cancer. Urol J 12, 2057–2064.
Wiren S, H€aggstr€om C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen
D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S,
Stocks T & Stattin P. (2014) Pooled cohort study on height and risk of
cancer and cancer death. Cancer Causes Control 25, 151–159.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of
this article:
Appendix S1 Information of age distribution and other characteristics of
men with and without TML.
Appendix S2 Patient’s soft drink and food consumption.
© 2017 American Society of Andrology and European Academy of Andrology Andrology, 2017, 5, 556–561 561
CHARACTERISTICS OF SYMPTOMATIC MEN ANDROLOGY
